Unknown

Dataset Information

0

Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer.

ABSTRACT: This study aimed to investigate the impact of underweight status on the prognosis of advanced-stage ovarian cancer. A total of 360 patients with stage III-IV epithelial ovarian cancer were enrolled and divided into three groups by body mass indexes (BMIs): underweight (BMI?

SUBMITTER: Kim SI 

PROVIDER: S-EPMC4094724 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer.

Kim Se Ik SI   Kim Hee Seung HS   Kim Tae Hun TH   Suh Dong Hoon DH   Kim Kidong K   No Jae Hong JH   Chung Hyun Hoon HH   Kim Yong Beom YB   Song Yong Sang YS  

Journal of immunology research 20140624

This study aimed to investigate the impact of underweight status on the prognosis of advanced-stage ovarian cancer. A total of 360 patients with stage III-IV epithelial ovarian cancer were enrolled and divided into three groups by body mass indexes (BMIs): underweight (BMI < 18.5 kg/m(2)); normal weight to overweight (18.5 kg/m(2) BMI < 27.5 kg/m(2)); obesity (BMI ≥ 27.5 kg/m(2)). Progression-free survival (PFS), overall survival (OS), CA-125, and neutrophil to lymphocyte ratio (NLR) as a marker  ...[more]

Similar Datasets

Unknown Latest research and treatment of advanced-stage epithelial ovarian cancer.
| S-EPMC3786558 | biostudies-literature
Unknown Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?
| S-EPMC4731146 | biostudies-literature
Unknown Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
| S-EPMC4095874 | biostudies-literature
Unknown Optimal treatment of early-stage ovarian cancer.
| S-EPMC4037858 | biostudies-other
Unknown Genomic aberrations relate early and advanced stage ovarian cancer.
| S-EPMC3396335 | biostudies-literature
Unknown Spatial analysis of advanced-stage ovarian cancer mortality in California.
| S-EPMC4485540 | biostudies-literature
Unknown Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.
| S-EPMC5584794 | biostudies-literature
Transcriptomics Transcriptome analysis the early and advanced stage of ovarian cancer
2021-11-30 | GSE161015 | GEO
Unknown The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis.
| S-EPMC6472063 | biostudies-literature
Unknown Targeted treatment of advanced ovarian cancer: spotlight on rucaparib.
| S-EPMC6223341 | biostudies-literature